Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 24, 2023

SELL
$283.23 - $323.1 $60,894 - $69,466
-215 Reduced 68.25%
100 $32,000
Q1 2023

May 23, 2023

BUY
$283.23 - $323.1 $60,894 - $69,466
215 Added 215.0%
315 $32,000
Q3 2022

Nov 08, 2022

BUY
$273.83 - $305.53 $27,383 - $30,552
100 New
100 $29,000
Q1 2022

May 02, 2022

SELL
$221.42 - $260.97 $22,142 - $26,097
-100 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$187.49 - $221.1 $18,749 - $22,110
100 New
100 $20,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Old North State Trust, LLC Portfolio

Follow Old North State Trust, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old North State Trust, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old North State Trust, LLC with notifications on news.